Researchers discover how tumor-killing immune cells attack lymphomas in living mice

Researchers reveal that chimeric antigen receptor (CAR) T cells can induce tumor regression by directly targeting and killing cancer cells, uncovering new details of how these immune cells work and how their effectiveness could be improved in the treatment of non-Hodgkin’s lymphoma and other B cell cancers.

Leave a Reply

Your email address will not be published. Required fields are marked *